Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Yu

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Cell Host & Microbe|October 8, 2020
Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental ReservoirsKatharine Michelle Ng, Andrés Aranda-Díaz, Carolina Tropini, et al.
Clinical Genitourinary Cancer|December 17, 2024
Real-world Clinical Outcomes and Prognostic Factors in Neuroendocrine Prostate CancerRichard Gagnon, Ealia Khosh Kish, Sarah Cook, et al.
JAMA Network Open|June 27, 2023
Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With ChemoradiotherapySung Jun Ma, Michael Khan, Udit Chatterjee, et al.
Oral Oncology|August 7, 2022
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiationSung Jun Ma, Han Yu, Michael Khan, et al.
Oncogene|March 15, 2019
Novel K6-K14 keratin fusion enhances cancer stemness and aggressiveness in oral squamous cell carcinomaFuu-Jen Tsai, Ming-Tsung Lai, Jack Cheng, et al.
JAMA Network Open|December 8, 2022
Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck CancerSung Jun Ma, Han Yu, Brian Yu, et al.
Clinical and Translational Science|September 12, 2020
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2Russell M Petrak, Nathan C Skorodin, Nicholas W Van Hise, et al.
Cancer Research|November 9, 2022
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate CancerJonathan Chou, Emily A Egusa, Sinan Wang, et al.
Journal of Primary Care & Community Health|September 13, 2024
Feasibility and Methodology of a Pilot Free Blood Pressure Monitoring and Follow-Up Program at Two Free ClinicsGeorgios Mikos, Brian Yu, Jessica Balbin, et al.
Nature|June 24, 2021
Clonal fitness inferred from time-series modelling of single-cell cancer genomesSohrab Salehi, Farhia Kabeer, Nicholas Ceglia, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Cell Host & Microbe|October 8, 2020
Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental ReservoirsKatharine Michelle Ng, Andrés Aranda-Díaz, Carolina Tropini, et al.
Clinical Genitourinary Cancer|December 17, 2024
Real-world Clinical Outcomes and Prognostic Factors in Neuroendocrine Prostate CancerRichard Gagnon, Ealia Khosh Kish, Sarah Cook, et al.
JAMA Network Open|June 27, 2023
Association of Body Mass Index With Outcomes Among Patients With Head and Neck Cancer Treated With ChemoradiotherapySung Jun Ma, Michael Khan, Udit Chatterjee, et al.
Oral Oncology|August 7, 2022
Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiationSung Jun Ma, Han Yu, Michael Khan, et al.
Oncogene|March 15, 2019
Novel K6-K14 keratin fusion enhances cancer stemness and aggressiveness in oral squamous cell carcinomaFuu-Jen Tsai, Ming-Tsung Lai, Jack Cheng, et al.
JAMA Network Open|December 8, 2022
Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck CancerSung Jun Ma, Han Yu, Brian Yu, et al.
Clinical and Translational Science|September 12, 2020
Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2Russell M Petrak, Nathan C Skorodin, Nicholas W Van Hise, et al.
Cancer Research|November 9, 2022
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate CancerJonathan Chou, Emily A Egusa, Sinan Wang, et al.
Journal of Primary Care & Community Health|September 13, 2024
Feasibility and Methodology of a Pilot Free Blood Pressure Monitoring and Follow-Up Program at Two Free ClinicsGeorgios Mikos, Brian Yu, Jessica Balbin, et al.
Nature|June 24, 2021
Clonal fitness inferred from time-series modelling of single-cell cancer genomesSohrab Salehi, Farhia Kabeer, Nicholas Ceglia, et al.
Pageof 10